Neuropathic Pain Management In India: A Cross-Sectional Study Of Prescription Practices In India
- Author:
Arif A Faruqui
- Collective Name:
- Publication Type:Journal Article
- Keywords:
neuropathic pain;
nortriptyline;
pregabalin;
mecobalamin;
combination
- From:
Pacific Journal of Medical Sciences
2025;27(1):19-27
- CountryPapua New Guinea
- Language:English
-
Abstract:
Neuropathic pain presents significant clinical challenges due to its complex pathophysiology and varied
patient response to treatment. While multiple pharmacologic options are available, healthcare provider’s preferences and prescribing behaviors can influence treatment outcomes and patient adherence. This study aimed to evaluate the preferences of healthcare providers in India and their current prescription trends in the management of neuropathic pain. A cross-sectional survey was conducted among 755 practicing healthcare professionals across India, comprising 376 orthopedic specialists and 379 physicians. A structured questionnaire was used to assess preferred drug molecule from tricyclic antidepressant class, factors affecting drug selection (e.g., perceived efficacy, patient tolerability, cost), preferred combination and prescribing trends of Nortriptyline, Pregabalin and Mecobalamin (NPM) combination. Descriptive statistics were used to analyze the responses. Nortriptyline was the most preferred tricyclic antidepressant for neuropathic pain (40.98%), followed by amitriptyline (33.26%) and protriptyline (15.66%.
